1. Home
  2. SPRO vs UBFO Comparison

SPRO vs UBFO Comparison

Compare SPRO & UBFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRO
  • UBFO
  • Stock Information
  • Founded
  • SPRO 2013
  • UBFO 1987
  • Country
  • SPRO United States
  • UBFO United States
  • Employees
  • SPRO N/A
  • UBFO N/A
  • Industry
  • SPRO Biotechnology: Pharmaceutical Preparations
  • UBFO Major Banks
  • Sector
  • SPRO Health Care
  • UBFO Finance
  • Exchange
  • SPRO Nasdaq
  • UBFO Nasdaq
  • Market Cap
  • SPRO 162.1M
  • UBFO 162.0M
  • IPO Year
  • SPRO 2017
  • UBFO N/A
  • Fundamental
  • Price
  • SPRO $2.20
  • UBFO $8.86
  • Analyst Decision
  • SPRO Buy
  • UBFO
  • Analyst Count
  • SPRO 4
  • UBFO 0
  • Target Price
  • SPRO $5.00
  • UBFO N/A
  • AVG Volume (30 Days)
  • SPRO 789.2K
  • UBFO 29.1K
  • Earning Date
  • SPRO 08-04-2025
  • UBFO 08-05-2025
  • Dividend Yield
  • SPRO N/A
  • UBFO 5.46%
  • EPS Growth
  • SPRO N/A
  • UBFO N/A
  • EPS
  • SPRO N/A
  • UBFO 0.65
  • Revenue
  • SPRO $44,584,000.00
  • UBFO $44,636,000.00
  • Revenue This Year
  • SPRO N/A
  • UBFO N/A
  • Revenue Next Year
  • SPRO N/A
  • UBFO N/A
  • P/E Ratio
  • SPRO N/A
  • UBFO $13.54
  • Revenue Growth
  • SPRO N/A
  • UBFO N/A
  • 52 Week Low
  • SPRO $0.51
  • UBFO $7.30
  • 52 Week High
  • SPRO $3.22
  • UBFO $10.49
  • Technical
  • Relative Strength Index (RSI)
  • SPRO 33.44
  • UBFO 54.09
  • Support Level
  • SPRO $2.30
  • UBFO $8.63
  • Resistance Level
  • SPRO $2.45
  • UBFO $9.00
  • Average True Range (ATR)
  • SPRO 0.12
  • UBFO 0.21
  • MACD
  • SPRO -0.07
  • UBFO 0.00
  • Stochastic Oscillator
  • SPRO 2.80
  • UBFO 74.07

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About UBFO United Security Bancshares

United Security Bancshares operates as the holding for United Security Bank. It provides commercial banking services to the business and professional community, and individuals located in Fresno, Madera, Santa Clara, and Kern Counties. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company's primary sources of revenue are interest income from loans and investment securities.

Share on Social Networks: